Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Fate Therapeutics, Inc. (FATE)

« Back to company index

FATE Chatter Timeline

Stock Ticker for FATE

Most Active Tweeters for FATE

UserTweets
@AmericanBanking 4
@stockmktgenius 3
@firsttomarkets 2
@ZolmaxNews 2
@dailypoliticaln 2

Recent Tweets for FATE

TranscriptDaily @TranscriptDaily
Fate Therapeutics $FATE Rating Lowered to Hold at BidaskClub https://t.co/bd89VYUhK9
June 17th 2019, 4:06am
registrarjourn @registrarjourn
Fate Therapeutics $FATE Now Covered by Mizuho https://t.co/3sHvdrdDG8
June 16th 2019, 5:06am
EnterpriseLeade @EnterpriseLeade
Fate Therapeutics $FATE Now Covered by Mizuho https://t.co/QKWpmpZ5v2
June 16th 2019, 5:06am
stockmktgenius @stockmktgenius
$FATE Fate Therapeutics, Inc. - #LeaderPullBack Close: 17.83 Liq: $18M https://t.co/MDvZ4cvDIr
June 16th 2019, 12:06am
AmericanBanking @AmericanBanking
Financial Analysis: Genocea Biosciences $GNCA and Fate Therapeutics $FATE https://t.co/f1FF2ouHjS #stocks
June 15th 2019, 8:06pm
dailypoliticaln @dailypoliticaln
Mizuho Begins Coverage on Fate Therapeutics $FATE https://t.co/ieRmKDKd8I
June 15th 2019, 7:06am
WKRBNews @WKRBNews
BidaskClub Downgrades Fate Therapeutics $FATE to Hold https://t.co/GMyvHJqTN4 #markets
June 15th 2019, 1:06am
OlympiaReport @OlympiaReport
Mizuho Begins Coverage on Fate Therapeutics $FATE https://t.co/3Y2aiXSBCv
June 14th 2019, 4:06am
TradeFlags @TradeFlags
TD BUY $FATE at 17.58, Supp 16.02 Resis 20.25 R26 HiLo 74% T1Y 22 strong_buy 1.2 fwdPE -13.7 DIV N/A #Fate Thera… https://t.co/QV1e9PMyIk
June 13th 2019, 11:06pm
stockmktgenius @stockmktgenius
$FATE Fate Therapeutics, Inc. - #LeaderPullBack Close: 17.58 Liq: $14M https://t.co/MDvZ4cvDIr
June 13th 2019, 9:06pm
ZolmaxNews @ZolmaxNews
BidaskClub Lowers Fate Therapeutics $FATE to Hold https://t.co/bRcDK6B63T
June 13th 2019, 1:06pm
_L_E_U @_L_E_U
riding $FATE since $16.02, bouncing off that MA180 @mishtix888 @WebullGlobal https://t.co/VQZZjTj51W
June 13th 2019, 12:06pm
firsttomarkets @firsttomarkets
Fate Therapeutics, Inc. Initiated Coverage by Mizuho (Ranked 36th) to Buy $FATE #FATE https://t.co/4Ftj1ua6Xf
June 13th 2019, 10:06am
WatchlistN @WatchlistN
Fate Therapeutics $FATE Now Covered by Analysts at Mizuho https://t.co/Y1JCXdWO5G
June 13th 2019, 9:06am
AmericanBanking @AmericanBanking
Fate Therapeutics Inc $FATE Receives Average Rating of “Buy” from Analysts https://t.co/KJaMx6beQb #stocks
June 13th 2019, 2:06am
ZolmaxNews @ZolmaxNews
Fate Therapeutics Inc $FATE Receives Average Recommendation of “Buy” from Brokerages https://t.co/gLnh6MWU03
June 13th 2019, 2:06am
Tickeron @Tickeron
A.I.dvisor made a bearish call on $FATE, netting in a 12.79% gain over 3 weeks https://t.co/NV7zSxEZZc https://t.co/MWIBthrM55
June 12th 2019, 11:06pm
AmericanBanking @AmericanBanking
Fate Therapeutics $FATE Receives New Coverage from Analysts at Mizuho https://t.co/vkbrHyP0yA #stocks
June 12th 2019, 6:06pm
dispatchtribune @dispatchtribune
Fate Therapeutics $FATE Coverage Initiated by Analysts at Mizuho https://t.co/mnF9DBsaeM
June 12th 2019, 6:06pm
Gambiste1 @Gambiste1
RT @_B_I_O_T_E_C_H_: MIZUHO $FATE Initiating Coverage with BUY and $27 PT - Transformative Potential, Data in 2019
June 12th 2019, 6:06pm
PriceTargetsNet @PriceTargetsNet
$FATE RATING INITIATED AT MIZUHO SECURITIES USA. https://t.co/rKW5avkrYU
June 12th 2019, 4:06pm
_B_I_O_T_E_C_H_ @_B_I_O_T_E_C_H_
MIZUHO $FATE Initiating Coverage with BUY and $27 PT - Transformative Potential, Data in 2019
June 12th 2019, 4:06pm
IlliniJJ @IlliniJJ
$FATE, looks like I may have missed getting back in under $16
June 12th 2019, 2:06pm
FlynancialA @FlynancialA
$FATE keeps knocking on the 40 wk SMA (200 day SMA). $XBI https://t.co/IoXlX96FsB
June 12th 2019, 9:06am
Dadbod4evah @Dadbod4evah
Older but interesting ....not all NK r created equal $fate https://t.co/AGNLeMAsxS
June 11th 2019, 9:06pm
SwingTradeBot @SwingTradeBot
Recent $FATE technical alerts: Fell Below 50 DMA plus 6 more alerts... https://t.co/WlSx9Zwpdv
June 11th 2019, 3:06pm
OlympiaReport @OlympiaReport
Fate Therapeutics $FATE Coverage Initiated at Roth Capital https://t.co/LjbPebsLXU
June 10th 2019, 3:06am
TranscriptDaily @TranscriptDaily
Fate Therapeutics $FATE Now Covered by Analysts at Roth Capital https://t.co/HECDro5bqf
June 9th 2019, 7:06am
marc_milam @marc_milam
@AndysCycles $fate ! lol
June 8th 2019, 2:06pm
dispatchtribune @dispatchtribune
Fate Therapeutics $FATE Shares Down 7.1% https://t.co/65mG4KLtHu
June 8th 2019, 11:06am
dakotafinancial @dakotafinancial
Fate Therapeutics $FATE Now Covered by Roth Capital https://t.co/Y1MBSBrWuQ
June 8th 2019, 9:06am
AmericanBanking @AmericanBanking
Fate Therapeutics $FATE Now Covered by Roth Capital https://t.co/WlBS1WoC7z #stocks
June 7th 2019, 10:06am
firsttomarkets @firsttomarkets
Fate Therapeutics, Inc. Initiated Coverage by Roth Capital (Ranked 74th) to Neutral with $20PT $FATE #FATE https://t.co/4Ftj1ua6Xf
June 7th 2019, 10:06am
ConsumerFeed @ConsumerFeed
Fate Therapeutics $FATE Earns Neutral Rating from Analysts at Roth Capital https://t.co/6MtWwNnWzQ
June 7th 2019, 8:06am
Traderideas1 @Traderideas1
RT @BioStocks: $FATE initiated with a Neutral at Roth. PT $20
June 7th 2019, 6:06am
BioStocks @BioStocks
$FATE initiated with a Neutral at Roth. PT $20
June 7th 2019, 6:06am
TickerReport @TickerReport
Comparing Fate Therapeutics $FATE and Spark Therapeutics $ONCE https://t.co/KTSz2FqnXd
June 7th 2019, 3:06am
PriceTargetsNet @PriceTargetsNet
$FATE RATING INITIATED AT ROTH CAPITAL PARTNERS. https://t.co/rKW5av2QAk
June 7th 2019, 12:06am
macondailynews @macondailynews
Brokerages Expect Fate Therapeutics Inc $FATE Will Post Quarterly Sales of $1.34 Million https://t.co/2fIuA6qcGQ
June 6th 2019, 9:06pm
stockmktgenius @stockmktgenius
$FATE Fate Therapeutics, Inc. - #LeaderPullBack Close: 17.71 Liq: $14M https://t.co/MDvZ4cvDIr
June 6th 2019, 6:06pm
andyarca @andyarca
$FATE buyout?
June 6th 2019, 1:06pm
Smallbios1 @Smallbios1
Wow even $FATE is down almost -10% today .. what’s not getting destroyed ? This seems like a planned attempt to des… https://t.co/IQRRBaXcgK
June 6th 2019, 1:06pm
SwingTradeBot @SwingTradeBot
50 DMA Support today: $FATE $OSN ... https://t.co/aW7zteKP9U
June 6th 2019, 11:06am
brendan_49 @brendan_49
Any specific reason to doubt that $FATE enhanced (for persistence, CD16 expression, and CD16 affinity) NK cells wil… https://t.co/KeSYlPUZzi
June 5th 2019, 2:06pm
dailypoliticaln @dailypoliticaln
Spark Therapeutics $ONCE and Fate Therapeutics $FATE Critical Survey https://t.co/7qh87gZX6x
June 5th 2019, 2:06am
TheMarketsDaily @TheMarketsDaily
Fate Therapeutics Inc $FATE Expected to Post Earnings of -$0.30 Per Share https://t.co/tU2Htj4teW
June 4th 2019, 4:06pm
stocknewstimes @stocknewstimes
Brokerages Expect Fate Therapeutics Inc $FATE Will Post Quarterly Sales of $1.34 Million https://t.co/8aWNuDK7WW
June 4th 2019, 4:06pm
SleekMoneycom @SleekMoneycom
Brokerages Expect Fate Therapeutics Inc $FATE Will Post Quarterly Sales of $1.34 Million https://t.co/WCDvhBxQJV #investing
June 4th 2019, 4:06pm
JRMKE_ @JRMKE_
@BioEqman You do realize that all the patients being treated for $FATE NK-100 are in the PD stage of their disease… https://t.co/XBmZBgtpJv
June 4th 2019, 3:06am
TurboResearch @TurboResearch
@BioEqman @BioValues No haven't looked into $FATE but yes if they show improvement in expansion, persistence and tr… https://t.co/Z49aCrR5jw
June 4th 2019, 1:06am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.